Renalis, a digital health company committed to the treatment of pelvic health disorders, announced the close of its $824K Pre-Seed funding round led by the Healthcare Collaboration Fund. The round also includes participation from JumpStart Inc. as well as a mix of individual and private investors.

Renalis is committed to developing FDA-approved prescription digital therapeutics for the treatment of pelvic health disorders. The company was founded in 2017 by Missy Lavender, who has suffered from pelvic health disorders, including OAB since the birth of her first child twenty years ago. Renalis' first commercial platform is a digital therapeutic for Overactive Bladder (OAB), which affects over 33 million Americans.